Christoph Ohlmeier
Impact in
-
- Heart Failure Treatment and Management
- Atrial Fibrillation Management and Outcomes
- Cardiovascular Function and Risk Factors
Papers in
-
- Heart Failure Treatment and Management 5
-
- Health Promotion and Cardiovascular Prevention 2
- Co-authors
- Edeltraut Garbe (10 shared papers)Rafael Mikolajczyk (7 shared papers)Wilhelm Haverkamp (3 shared papers)Johann Frick (2 shared papers)Holger Gothe (9 shared papers)Franziska Prütz (2 shared papers)Oliver Riedel (4 shared papers)Ingo Langner (4 shared papers)
- Journals
- PLoS ONE (2 papers)BMJ Open (2 papers)Orphanet Journal of Rare Diseases (2 papers)Clinical Research in Cardiology (2 papers)Pharmacoepidemiology and Drug Safety (1 paper)
- Partner nations
- GermanyAustriaSwitzerland
In The Last Decade
Christoph Ohlmeier
28 papers receiving 411 citations
Peers
Comparison fields: 5 of 65
- Cardiology and Cardiovascular Medicine 105
- Internal Medicine 10
- Genetics 21
- Pathology and Forensic Medicine 29
- General Health Professions 34
Countries citing papers authored by Christoph Ohlmeier
This map shows the geographic impact of Christoph Ohlmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Ohlmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Ohlmeier more than expected).
Fields of papers citing papers by Christoph Ohlmeier
This network shows the impact of papers produced by Christoph Ohlmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Ohlmeier. The network helps show where Christoph Ohlmeier may publish in the future.
Co-authors
The 25 scholars most cited alongside Christoph Ohlmeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 65 | |
| 2 | 2014 | 44 | |
| 3 | 2013 | 37 | |
| 4 | 2015 | 34 | |
| 5 | 2019 | 32 | |
| 6 | 2018 | 26 | |
| 7 | 2020 | 23 | |
| 8 | 2016 | 22 | |
| 9 | 2020 | 20 | |
| 10 | 2019 | 16 | |
| 11 | 2024 | 11 | |
| 12 | 2019 | 11 | |
| 13 | 2020 | 9 | |
| 14 | 2017 | 9 | |
| 15 | 2020 | 9 | |
| 16 | 2009 | 7 | |
| 17 | 2023 | 7 | |
| 18 | 2018 | 7 | |
| 19 | 2022 | 6 | |
| 20 | 2015 | 6 |
About Christoph Ohlmeier
Christoph Ohlmeier is a scholar working on Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine, Genetics and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 420 indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (5 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Potassium and Related Disorders (2 papers), Health Promotion and Cardiovascular Prevention (2 papers), Hemophilia Treatment and Research (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper), Advanced Causal Inference Techniques (1 paper) and Substance Abuse Treatment and Outcomes (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (105 citations), Internal Medicine (10 citations), Genetics (21 citations), Pathology and Forensic Medicine (29 citations) and General Health Professions (34 citations). Christoph Ohlmeier has collaborated with scholars based in Germany, Austria and Switzerland. Frequent co-authors include Edeltraut Garbe, Rafael Mikolajczyk, Wilhelm Haverkamp, Johann Frick, Holger Gothe, Franziska Prütz, Oliver Riedel, Ingo Langner, Niklas Schmedt and Kai‐Uwe Saum. Their work appears in journals such as PLoS ONE, BMJ Open, Orphanet Journal of Rare Diseases, Clinical Research in Cardiology and Pharmacoepidemiology and Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.